Graphite Bio, Inc. has placed 14 000 000 shares of common stock in an IPO priced $17 per share, that is the upper limit of the previously announced range ($15-17).
Besides, Graphite has granted the underwriters a 30-day option to purchase up to 2 100 000 shares at the public offering price.
The trading debut will take place on the Nasdaq Global Select Market on June 15, 2021 under the ticker symbol “GRPH”.